JP2017537934A - ケロイド瘢痕を処置するためのフィビュリン−５の使用 - Google Patents

ケロイド瘢痕を処置するためのフィビュリン−５の使用 Download PDF

Info

Publication number
JP2017537934A
JP2017537934A JP2017530302A JP2017530302A JP2017537934A JP 2017537934 A JP2017537934 A JP 2017537934A JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017537934 A JP2017537934 A JP 2017537934A
Authority
JP
Japan
Prior art keywords
fibulin
keloid
cells
cell
fibroblast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017530302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537934A5 (enExample
Inventor
モシェ ワイ． フルゲルマン，
モシェ ワイ． フルゲルマン，
Original Assignee
ヴェッスル セラピューティクス リミテッド
ヴェッスル セラピューティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴェッスル セラピューティクス リミテッド, ヴェッスル セラピューティクス リミテッド filed Critical ヴェッスル セラピューティクス リミテッド
Publication of JP2017537934A publication Critical patent/JP2017537934A/ja
Publication of JP2017537934A5 publication Critical patent/JP2017537934A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1741—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals alpha-Glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017530302A 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用 Pending JP2017537934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462088607P 2014-12-07 2014-12-07
US62/088,607 2014-12-07
PCT/IL2015/051187 WO2016092542A1 (en) 2014-12-07 2015-12-07 Use of fibulin-5 for the treatment of keloid scars

Publications (2)

Publication Number Publication Date
JP2017537934A true JP2017537934A (ja) 2017-12-21
JP2017537934A5 JP2017537934A5 (enExample) 2019-01-24

Family

ID=56106831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017530302A Pending JP2017537934A (ja) 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用

Country Status (4)

Country Link
US (1) US20190030125A1 (enExample)
EP (1) EP3226886A4 (enExample)
JP (1) JP2017537934A (enExample)
WO (1) WO2016092542A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3312608B1 (en) * 2016-10-24 2019-10-02 Akribes Biomedical GmbH Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
JP6859363B2 (ja) * 2016-11-30 2021-04-14 株式会社 資生堂 肌特性解析方法
CA3074440A1 (en) * 2017-09-01 2019-03-07 Excel Med, Llc Pharmaceutical composition for treating keloid and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093057A1 (ja) * 2004-03-29 2005-10-06 Kyoto University 切断型ｄａｎｃｅ、ｄａｎｃｅ複合体、及びこれらを用いる方法
WO2006082763A1 (ja) * 2005-02-07 2006-08-10 Kyoto University Ｄａｎｃｅまたはその発現を増強する因子による弾性線維再生の方法
WO2009072654A1 (ja) * 2007-12-07 2009-06-11 Seikagaku Corporation ケロイド及び肥厚性瘢痕根治治療剤
JP2011212437A (ja) * 2010-03-17 2011-10-27 Gunze Ltd Ｄａｎｃｅタンパク質含有徐放基材及び該徐放基材の製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300810A2 (hu) * 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
WO2008152507A2 (en) * 2007-03-16 2008-12-18 Multigene Vascular Systems, Inc. Compositions and methods for treating ophthalmic disorders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093057A1 (ja) * 2004-03-29 2005-10-06 Kyoto University 切断型ｄａｎｃｅ、ｄａｎｃｅ複合体、及びこれらを用いる方法
WO2006082763A1 (ja) * 2005-02-07 2006-08-10 Kyoto University Ｄａｎｃｅまたはその発現を増強する因子による弾性線維再生の方法
WO2009072654A1 (ja) * 2007-12-07 2009-06-11 Seikagaku Corporation ケロイド及び肥厚性瘢痕根治治療剤
JP2011212437A (ja) * 2010-03-17 2011-10-27 Gunze Ltd Ｄａｎｃｅタンパク質含有徐放基材及び該徐放基材の製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DNA AND CELL BIOLOGY, vol. 23, no. 6, JPN6019033246, 2004, pages 367 - 379, ISSN: 0004243488 *
J AM ACAD DERMATOL, vol. 50, no. 6, JPN6019033245, 2004, pages 850 - 853, ISSN: 0004243487 *

Also Published As

Publication number Publication date
WO2016092542A1 (en) 2016-06-16
US20190030125A1 (en) 2019-01-31
EP3226886A4 (en) 2018-07-25
EP3226886A1 (en) 2017-10-11

Similar Documents

Publication Publication Date Title
KR101830926B1 (ko) 피부 노화를 방지 및/또는 개선하기 위해 사용되는 pedf-유도 폴리펩티드의 용도
JP2015533798A (ja) 皮膚瘢痕を治療する組成物及び方法
US20150087597A1 (en) Polypeptides and methods of use
CA2512512A1 (en) Uses of hmgb, hmgn, hmga proteins
KR20070100329A (ko) 콜라겐 합성 및/또는 kgf 발현의 촉진 방법
BR122020010515B1 (pt) Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
Lv et al. Cartilage oligomeric matrix protein fine-tunes disturbed flow-induced endothelial activation and atherogenesis
DK2244724T3 (en) Use of peptides for promoting wound healing
KR20140140396A (ko) 피부 주름 개선 및 미백용 조성물
KR20160136342A (ko) 모발 성장의 억제를 위한 오스테오폰틴 유도체를 포함하는 조성물
JP2017537934A (ja) ケロイド瘢痕を処置するためのフィビュリン−５の使用
JP2015513905A (ja) カドヘリン調節に基づく組成物および処置
WO2006135783A2 (en) Compositions and methods for modulating angiogenesis
US20230331814A1 (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
KR101721228B1 (ko) 지방유래 줄기세포의 배양액을 유효성분으로 포함하는 발모촉진용 조성물
US20160244759A1 (en) Compositions and treatments based on cadherin modulation
EP2275437A1 (en) Polypeptide and pharmaceutical composition containing the polypeptide
JP2001213898A (ja) インテグリン活性化作用を有する生理活性ペプチドおよびそれを含有する治療剤
KR20250169359A (ko) 성장인자인 fgf 및 scf를 전달하는 세포 투과성 펩타이드 및 이의 상처 치유용 조성물
BR112019007563B1 (pt) Peptídeos derivados da fibronectina com bioatividade melhorada e suscetibilidade reduzida à degradação da elastase neutrófila
Bauer et al. Molecular and Cellular Biology of Derman Fibroproliferative Disorders
HK40006015A (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
NZ752999B2 (en) Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
HK1152717A1 (en) Angiogenic peptide
HK1147502A (en) Polypeptide and pharmaceutical composition containing the polypeptide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170614

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170607

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190830

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200331